Pfizer Inc. (PFE)

Pfizer Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,343	1,043	2,853	416	1,944	1,786
Short-Term Investments	13,641	19,434	9,837	22,316	29,125	10,437
Trading Asset Securities	-	-	-	-	4	18
Cash & Short-Term Investments	14,984	20,477	12,690	22,732	31,073	12,241
Cash Growth	50.55%	61.36%	-44.18%	-26.84%	153.84%	26.21%
Accounts Receivable	14,260	11,463	11,566	10,952	11,479	7,913
Other Receivables	3,855	3,314	3,978	3,577	4,266	3,264
Receivables	18,115	14,777	15,544	14,529	15,745	11,177
Inventory	11,468	10,851	10,189	8,981	9,059	8,020
Other Current Assets	2,357	4,253	4,910	5,017	3,816	3,629
Total Current Assets	46,924	50,358	43,333	51,259	59,693	35,067
Property, Plant & Equipment	18,880	20,682	21,864	19,276	17,721	15,131
Long-Term Investments	2,056	2,107	15,382	14,926	21,348	20,379
Goodwill	69,101	68,527	67,783	51,375	49,208	49,556
Other Intangible Assets	51,324	55,411	64,900	43,370	25,146	28,337
Long-Term Deferred Tax Assets	11,048	6,600	1,800	4,800	1,600	900
Other Long-Term Assets	9,398	9,711	11,439	12,199	6,760	4,859
Total Assets	208,731	213,396	226,501	197,205	181,476	154,229
Accounts Payable	5,024	5,633	6,710	6,809	5,578	4,283
Accrued Expenses	12,818	12,005	9,224	8,316	7,671	6,498
Short-Term Debt	56	3,199	8,096	385	605	701
Current Portion of Long-Term Debt	4,257	3,775	2,270	2,570	1,636	2,002
Current Portion of Leases	-	356	527	620	449	320
Current Income Taxes Payable	3,799	2,910	2,349	1,587	1,266	1,049
Current Unearned Revenue	924	1,511	2,700	2,520	3,067	2,070
Other Current Liabilities	9,718	13,606	15,918	19,331	22,399	8,997
Total Current Liabilities	36,596	42,995	47,794	42,138	42,671	25,920
Long-Term Debt	57,625	57,802	61,813	33,205	36,195	37,133
Long-Term Leases	-	2,286	2,626	2,597	2,510	1,108
Pension & Post-Retirement Benefits	2,157	2,115	2,167	2,250	3,724	5,411
Long-Term Deferred Tax Liabilities	2,467	2,122	640	1,023	349	4,063
Other Long-Term Liabilities	16,790	17,579	22,173	20,075	18,564	17,121
Total Liabilities	115,635	124,899	137,213	101,288	104,013	90,756
Common Stock	481	480	478	476	473	470
Additional Paid-In Capital	94,248	93,603	92,631	91,802	90,591	88,674
Retained Earnings	121,150	116,725	118,353	125,656	103,394	90,392
Treasury Stock	-115,011	-114,763	-114,487	-113,969	-111,361	-110,988
Comprehensive Income & Other	-8,067	-7,842	-7,961	-8,304	-5,896	-5,310
Total Common Equity	92,801	88,203	89,014	95,661	77,201	63,238
Minority Interest	295	294	274	256	262	235
Shareholders' Equity	93,096	88,497	89,288	95,917	77,463	63,473
Total Liabilities & Equity	208,731	213,396	226,501	197,205	181,476	154,229
Total Debt	61,938	67,418	75,332	39,377	41,395	41,264
Net Cash (Debt)	-46,954	-46,941	-62,642	-16,645	-10,322	-29,023
Net Cash Per Share	-8.23	-8.24	-10.97	-2.90	-1.81	-5.15
Filing Date Shares Outstanding	5,686	5,667	5,647	5,619	5,623	5,578
Total Common Shares Outstanding	5,686	5,667	5,646	5,616	5,620	5,567
Working Capital	10,328	7,363	-4,461	9,121	17,022	9,147
Book Value Per Share	16.32	15.56	15.77	17.03	13.74	11.36
Tangible Book Value	-27,624	-35,735	-43,669	916	2,847	-14,655
Tangible Book Value Per Share	-4.86	-6.31	-7.73	0.16	0.51	-2.63
Land	-	291	353	368	423	443
Buildings	-	9,036	9,046	8,832	9,001	8,998
Machinery	-	20,612	19,661	17,373	16,710	15,484
Construction In Progress	-	4,937	5,925	4,875	3,822	3,481

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q